Baxter International Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
535.49 M |
Public Float |
503.78 M |
Baxter International Inc. | |
Stock Exchange | Mexican Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
535.49 M |
Public Float |
503.78 M |
Baxter International Inc. | |
Stock Exchange | New York Stock Exchange |
EPS |
$2.94 |
Market Cap |
$41.84 B |
Shares Outstanding |
510.17 M |
Public Float |
511.36 M |
Address |
One Baxter Parkway Deerfield Illinois 60015 United States |
Employees | - |
Website | http://www.baxter.com |
Updated | 07/08/2019 |
Baxter International, Inc. provides a broad portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |